The Role of Emollients in Managing Stasis Eczema: Current Evidence and Clinical Application
Dermatologic Therapy · 2026-01 · 2026 (1)
DOI: 10.1155/dth/3155073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatologic Therapy, online erschienen am 23.06.2026. Verfasst von Imran Al-Jameel und 2 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universiti Kebangsaan Malaysia.
Abstract (Originalsprache)
Background
Stasis eczema, a chronic inflammatory dermatosis associated with chronic venous insufficiency (CVI), remains comparatively underresearched among eczematous dermatoses, particularly in the context of the ideal long‐term management strategy. While the role of emollients in epidermal barrier repair and hydration is well established, there are gaps in knowledge regarding the elucidation of their precise mechanisms for modulating inflammation, preventing exacerbation, and improving adherence in this patient population.
Objectives
The pathophysiology of stasis eczema is reviewed here with emphasis on the interlinked relationship between venous hypertension, cytokine imbalance (e.g., TNF‐α, IL‐1, and IL‐6), and epidermal barrier disruption. Emollients, formulated with occlusive agents (e.g., petrolatum), humectants (e.g., urea), and lipid‐replenishing additives (e.g., ceramides), offer targeted skin hydration and barrier repair. The choice of formulations remains paramount with lotions for mild disease, creams for balanced hydration and occlusion in moderate disease, and ointments for maximal protection in severe disease, though potentially at the possible expense of adherence.
Methods
A literature review in the narrative approach was carried out by conducting a search on electronic databases such as PubMed, Scopus, Google Scholar, and Web of Science. Various sets of keywords were used to identify appropriate English literature regarding the topics of stasis eczema, CVI, skin barrier dysfunction, and emollient therapy. The review also included clinically useful experimental studies, observational studies, and review articles, in addition to randomized controlled trials, to gain a broad picture of the current evidence.
Results
Evidence in this field highlights short‐term outcomes like enhanced skin elasticity and reduced pruritus, but long‐term data regarding flare‐up prevention and combination therapy with adjunctive treatment are sparse. Additionally, limitations to adherence such as cost, cosmetic acceptability, and contact sensitization deserve greater research.
Conclusions
This review consolidates the evidence for emollient efficacy, summarizes gaps in knowledge regarding the development of formulations coupled with anti‐inflammatory or antimicrobial agents, and outlines measures to maximize patient adherence by personalizing regimens, postbath application, and patient education on prophylactic use, all aimed at improving outcomes and quality of life.
Förderung
- Universiti Kebangsaan Malaysia
Zitieren
APA
Al-Jameel, I., Zhu, Y., & Goon, J. A. (2026). The Role of Emollients in Managing Stasis Eczema: Current Evidence and Clinical Application. Dermatologic Therapy, 2026(1). https://doi.org/10.1155/dth/3155073
Vancouver
Al-Jameel I, Zhu Y, Goon JA. The Role of Emollients in Managing Stasis Eczema: Current Evidence and Clinical Application. Dermatologic Therapy. 2026;2026(1). doi:10.1155/dth/3155073
BibTeX
@article{AlJameel2026,
author = {Al-Jameel, Imran and Zhu, Yuezhi and Goon, Jo Aan},
title = {The Role of Emollients in Managing Stasis Eczema: Current Evidence and Clinical Application},
journal = {Dermatologic Therapy},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/dth/3155073}
}
EUVIMED